We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Recalls Weight Loss Drug, Gets FDA Warning Letter
GSK Recalls Weight Loss Drug, Gets FDA Warning Letter
GlaxoSmithKline alerted consumers that five lots of its OTC weight loss drug Alli may have been tampered with after fielding complaints that a different drug was in some of the bottles.